Praxis Medical Insights

Mechanisms and Adverse Effects

Adrenal suppression occurs in approximately 50% of patients after withdrawal of medium/high-dose therapy, presenting with weakness, fatigue, and other symptoms that can mimic the underlying disease 1
Steroid withdrawal syndrome can present with weakness, fatigue, loss of appetite, weight loss, and other symptoms when tapering corticosteroids 1
Higher doses and longer treatment duration of prednisone increase the risk of adverse effects, including fatigue 3

The National Comprehensive Cancer Network recommends the use of corticosteroids, including prednisone, for short-term relief of cancer-related fatigue and improving quality of life 2
Use of prednisone to manage fatigue should be restricted to specific populations, such as terminally ill patients, those with fatigue and concomitant anorexia, or patients with pain related to brain or bone metastases 2
Regular reevaluation of fatigue and other symptoms is essential during prednisone therapy 2
Ensure adequate calcium (800-1000 mg/day) and vitamin D (800 IU/day) supplementation during treatment 1
Address any metabolic disturbances, such as monitoring blood glucose and potassium levels, if fatigue develops or worsens during prednisone therapy 3

Response to prednisone varies significantly between individuals 3
While prednisone may provide short-term relief of fatigue in some conditions, long-term use often leads to adverse effects, including fatigue 2
Evidence for corticosteroid use in cancer-related fatigue is of very low certainty, and careful monitoring and individualized management are essential when using prednisone in patients experiencing fatigue 2